Horhausen, Germany

Peter Bohnenkämper

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Lts Lohmann Therapie-Systeme Ag. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Peter Bohnenkämper

Introduction

Peter Bohnenkämper is a notable inventor based in Horhausen, Germany. He has made significant contributions to the field of transdermal therapeutic systems, particularly in the formulation of active agents for medicinal use. His work exemplifies the intersection of innovation and healthcare, showcasing the potential of new technologies in improving patient outcomes.

Latest Patents

Peter Bohnenkämper holds a patent for a transdermal therapeutic system that includes an active agent impermeable backing layer, at least one adhesive layer comprising at least 70% by weight of at least one polysiloxane polymer, tetrahydrocannabinol (THC), and at least one solubilizer. This innovative formulation also includes an optional protective layer for removal before use, along with a method for its preparation and its application as a medicament. He has 1 patent to his name, reflecting his commitment to advancing medical technology.

Career Highlights

Bohnenkämper is associated with LTS Lohmann Therapie-Systeme AG, a company known for its pioneering work in the development of transdermal drug delivery systems. His role at the company has allowed him to contribute to groundbreaking research and development efforts in the pharmaceutical industry.

Collaborations

Throughout his career, Peter has collaborated with talented professionals such as Eva-Marie Prinz and Marco Emgenbroich. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Peter Bohnenkämper's work in the field of transdermal therapeutic systems highlights the importance of innovation in medicine. His contributions not only advance technology but also improve the quality of life for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…